Resveratrol exhibits differential protective effects on fast- and slow-twitch muscles in streptozotocin-induced diabetic rats

Journal of Diabetes

Volumn 6, Issue 1, 2014, Pages 60-67

  Chang, Chih Chun ^a   Yang, Meng Hsuan ^b   Tung, Hung Chun ^b   Chang, Chieh Yu ^c   Tsai, Yu Lin ^c   Huang, Jiung Pang ^b   Yen, Tzung Hai ^d   Hung, Li Man ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b Department and Graduate Institute of Biomedical Sciences ^*  (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Diabetic myopathy; Glycogen synthase kinase 3; Oxidative stress; Resveratrol; Type 1 diabetes

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLYCOGEN SYNTHASE KINASE 3; LUCIGENIN; MANGANESE SUPEROXIDE DISMUTASE; PROTECTIVE AGENT; PROTEIN KINASE B; RESVERATROL; STREPTOZOCIN; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; FAST MUSCLE FIBER; MALE; MUSCLE TWITCH; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SLOW MUSCLE FIBER; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

DIABETIC MYOPATHY; GLYCOGEN SYNTHASE KINASE 3; OXIDATIVE STRESS; RESVERATROL; TYPE 1 DIABETES;

ACETYL-COA CARBOXYLASE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; GLYCOGEN SYNTHASE KINASE 3; INSULIN; MALE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, LONG-EVANS; SIGNAL TRANSDUCTION; STILBENES; SUPEROXIDE DISMUTASE; SUPEROXIDES; TRIGLYCERIDES;

EID: 84889669027     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12072     Document Type: Article

References (31)

1. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes. 2009; 12: 195-203.
2. Hamilton J, Daneman D. Deteriorating diabetes control during adolescence: Physiological or psychosocial? J Pediatr Endocrinol Metab. 2002; 15: 115-126.
3. Reske-Nielsen E, Harmsen A, Vorre P. Ultrastructure of muscle biopsies in recent, short-term and long-term juvenile diabetes. Acta Neurol Scand. 1977; 55: 345-362.
4. Jakobsen J, Reske-Nielsen E. Diffuse muscle fiber atrophy in newly diagnosed diabetes. Clin Neuropathol. 1986; 5: 73-77.
5. Rodrigues L, Crisóstomo J, Matafome P, Louro T, Nunes E, Seiça R. Dietary restriction improves systemic and muscular oxidative stress in type 2 diabetic Goto-Kakizaki rats. J Physiol Biochem. 2011; 67: 613-619.
6. Laughlin MH, Roseguini B. Mechanisms for exercise training-induced increases in skeletal muscle blood flow capacity: Differences with interval sprint training versus aerobic endurance training. J Physiol Pharmacol. 2008; 7: 71-88.
7. Saltin B, Henriksson J, Nygaard E, Andersen P, Jansson E. Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann N Y Acad Sci. 1977; 301: 3-29.
8. Biering-Sørensen B, Kristensen IB, Kjaer M, Biering-Sørensen F. Muscle after spinal cord injury. Muscle Nerve. 2009; 40: 499-519.
9. Fritzsche K, Blüher M, Schering S etal. Metabolic profile and nitric oxide synthase expression of skeletal muscle fibers are altered in patients with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2008; 116: 606-613.
10. Oberbach A, Bossenz Y, Lehmann S etal. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care. 2006; 29: 895-900.
11. Klueber KM, Feczko JD. Ultrastructural, histochemical, and morphometric analysis of skeletal muscle in a murine model of type I diabetes. Anat Rec. 1994; 239: 18-34.
12. Gordon CS, Serino AS, Krause MP etal. Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: A model of adolescent type 1 diabetic myopathy? PLoS ONE. 2010; 5: e14032.
13. Palsamy P, Sivakumar S, Subramanian S. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats. Chem Biol Interact. 2010; 186: 200-210.
14. Huang JP, Huang SS, Deng JY, Chang CC, Day YJ, Hung LM. Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin. Free Radic Biol Med. 2010; 49: 1710-1721.
15. Palsamy P, Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol. 2010; 224: 423-432.
16. Chang CC, Chang CY, Wu YT, Huang JP, Yen TH, Hung LM. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase. J Biomed Sci. 2011; 18: 47.
17. Arrick DM, Sun H, Patel KP, Mayhan WG. Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats. Am J Physiol Heart Circ Physiol. 2011; 301: H696-703.
18. Dirks Naylor AJ. Cellular effects of resveratrol in skeletal muscle. Life Sci. 2009; 84: 637-640.
19. Chi TC, Chen WP, Chi TL etal. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci. 2007; 80: 1713-1720.
20. Park CE, Kim MJ, Lee JH etal. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp Mol Med. 2007; 39: 222-229.
21. Bravard A, Bonnard C, Durand A etal. Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Am J Physiol Endocrinol Metab. 2011; 300: E581-591.
22. Matsunami T, Sato Y, Sato T, Ariga S, Shimomura T, Yukawa M. Oxidative stress and gene expression of antioxidant enzymes in the streptozotocin-induced diabetic rats under hyperbaric oxygen exposure. Int J Clin Exp Pathol. 2009; 3: 177-188.
23. Resmi H. The combination of bortezomib and resveratrol may prevent muscle wasting in diabetes. Med Hypotheses. 2011; 76: 291-292.
24. Gregersen S, Samocha-Bonet D, Heilbronn LK, Campbell LV. Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans. J Nutr Metab. 2012; 2012: 238056.
25. Ikizler M, Ovali C, Dernek S etal. Protective effects of resveratrol in ischemia-reperfusion injury of skeletal muscle: A clinically relevant animal model for lower extremity ischemia. Chin J Physiol. 2006; 49: 204-209.
26. Zou F, Mao XQ, Wang N, Liu J, Ou-Yang JP. Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK. Acta Pharmacol Sin. 2009; 30: 1607-1615.
27. Barger JL, Kayo T, Vann JM etal. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE. 2008; 3: e2264.
28. Welsh GI, Wilson C, Proud CG. GSK3: A SHAGGY frog story. Trends Cell Biol. 1996; 6: 274-279.
29. Srivastava AK, Pandey SK. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol Cell Biochem. 1998; 182: 135-141.
30. Henriksen EJ. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes. Curr Diabetes Rev. 2010; 6: 285-293.
31. Meeprom A, Sompong W, Suwannaphet W, Yibchok-anun S, Adisakwattana S. Grape seed extract supplementation prevents high-fructose diet-induced insulin resistance in rats by improving insulin and adiponectin signalling pathways. Br J Nutr. 2011; 106: 1173-1181.